Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 129 | 1 | 130 | +2 |
| Shares | 57.9M | 4.00M | 58.7M | +4.72M (+8.8%) |
| Value | $626.9M | $43.3M | $700.3M | +$116.7M (+20.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 3,847,471 | $45.9M | 0.00% |
| Pictet Asset Management Holding SA | 1,667,459 | $19.9M | 0.02% |
| Balyasny Asset Management LLC | 709,097 | $8.47M | 0.02% |
| HRT Financial LP | 108,852 | $1.30M | 0.01% |
| Ikarian Capital, LLC | 92,000 | $1.10M | 0.34% |
| Millennium Management LLC | 78,060 | $932.0K | 0.00% |
| ExodusPoint Capital Management, LP | 69,841 | $834.0K | 0.01% |
| J. Goldman & Co LP | 33,750 | $403.0K | 0.02% |
| Boothbay Fund Management, LLC | 28,170 | $336.4K | 0.01% |
| Dynamic Technology Lab Private Ltd | 19,894 | $238.0K | 0.03% |
| Caption Management, LLC | 17,600 | $210.1K | 0.02% |
| Intech Investment Management LLC | 13,686 | $163.4K | 0.00% |
| SG Americas Securities, LLC | 13,056 | $156.0K | 0.00% |
| Portland Investment Counsel Inc. | 12,000 | $143.3K | 0.05% |
| ProShare Advisors LLC | 10,928 | $130.5K | 0.00% |
| Federation des caisses Desjardins du Quebec | 2,000 | $23.9K | 0.00% |
| Quest Partners LLC | 1,903 | $22.7K | 0.00% |
| Truvestments Capital LLC | 838 | $10.0K | 0.00% |
| Sterling Capital Management LLC | 105 | $1.25K | 0.00% |
Sold out (17)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Polar Capital Holdings Plc | 1,000,000 | $10.8M |
| Affinity Asset Advisors, LLC | 275,000 | $2.98M |
| Atom Investors LP | 34,515 | $373.5K |
| Connor, Clark & Lunn Investment Management Ltd. | 28,167 | $304.8K |
| Susquehanna Portfolio Strategies, LLC | 26,549 | $287.3K |
| Brevan Howard Capital Management LP | 22,328 | $241.6K |
| ADAR1 Capital Management, LLC | 20,076 | $217.2K |
| Verition Fund Management LLC | 18,539 | $200.6K |
| Alpine Global Management, LLC | 15,857 | $171.6K |
| Cubist Systematic Strategies, LLC | 13,416 | $145.2K |
| Bayesian Capital Management, LP | 12,129 | $131.2K |
| AQR Capital Management LLC | 12,125 | $131.2K |
| Catalyst Funds Management Pty Ltd | 1,900 | $20.6K |
| Russell Investments Group, Ltd. | 1,018 | $11.0K |
| Simplex Trading, LLC | 736 | $7.00K |
| Pacer Advisors, Inc. | 580 | $6.28K |
| Abich Financial Wealth Management LLC | 10 | $108 |
Not filed for Q3 2024 yet (1)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,999,518 | $43.3M |